PCI – 7th June 2024
Thermofisher: Thu 29 February 2024, 11:15

Current Edition

Cell and Gene Therapy

Upcoming Events

SLAS Europe – 7th April 2025
PEGS Boston – 17/02/2025
Biotechnology Show 2025: 20th January 2025

Advertisement

Fujifilm rectangle: Fri 22 November 2024, 14:23
Roald Dahl Charity: Fri 15 November 2024, 12:57
A&M STABTEST: Fri 21 June 2024, 11:43
CDD Vault – 18.03.2025
Biopharma Group – 19th March 2025
news

Biopharma Takes on Deadly Brain Cancer After Decades of Failure

Emboldened by technological advances and a deeper knowledge of glioblastoma, Merck, Kazia Therapeutics, CorriXR Therapeutics and others are targeting the often-fatal...
Continue Reading →
news

Abingworth ‘Will Launch $1.5bn Fund for Co-developed Drugs’

Venture capital group Abingworth is reportedly trying to raise up to $1.5 billion in investment funding to support biopharma companies' clinical development programm...
Continue Reading →
news

Sanofi Opens $590M Modular Vaccine, Biologics Plant in Singapore

Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be reconfigured within days during a pan...
Continue Reading →
news

FDA Oncology Advisory Committee to Weigh Exelixis’ Cabometyx in Neuroendocrine Tumours

The advisory committee will meet to discuss Cabometyx's phase 3 CABINET study in March 2025. Before Exelexis’ Cabometyx can pass muster with the FDA in its hopefu...
Continue Reading →
Volume 4 Issue 4

How Involved Should Biopharma CEOs Be In Outsourcing Activities?

When outsourcing drug development and manufacturing, how involved should the CEOs of emerging biopharma be in the requisite day-to-day activities and processes? Louis...
Continue Reading →
news

Prestige Biopharma and Alvogen Announce License and Supply Agreement to Commercialize Prestige´s Trastuzumab Biosimilar (Hervelous™) in Central and Eastern Europe Singapore

Prestige BioPharma and Alvogen today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercia...
Continue Reading →
news

Alpha Biopharma announces series A financing

 AZD3759, AlphaBio's lead product, is a next-generation small molecule tyrosine kinase inhibitor (TKI). It is specifically designed to treat epidermal growth factor r...
Continue Reading →
news

Wize Pharma signs distribution agreement in China for LO2A

HPGC is a division of Harbin Pharmaceutical Group Co. Ltd., one of China's largest healthcare companies with 20,000 employees and assets worth $2.9 billion. Wize P...
Continue Reading →
news

Johnson & Johnson has the most bucks for biopharma M&A, Astellas the easiest target: analyst

The $62 billion Takeda-Shire deal surprised everyone—and worries some—as Takeda is borrowing an enormous $31 billion to help pay for the purchase. Does it refresh the...
Continue Reading →
Biopharma Group
A-D

Biopharma Group

The Biopharma Group comprises of Biopharma Process Systems (BPS), Biopharma Technologies Ltd (BTL), Biopharma Technology LLC (USA) and Biopharma Technologies France (...
Continue Reading →
Newcells 3 June 2024, 15:12
Aldevron: 16th January 2025
Richter: Wed 23 October 2024, 09:03
Asychem – 10.04.2025
Eppendorf – 18.03.2025